Dr. Patrick Anquetil is Portal Instrument’s chief executive officer. Dr. Anquetil brings more than 18 years of experience leading high-tech bioengineering companies from the lab to the market place and building world-class teams. Prior to founding Portal Instruments, he was co-founder of SynapDx Corp., an autism diagnostic company. He also co-founded Aretais, Inc. backed by Pfizer in the area of non-invasive blood glucose detection. Dr. Anquetil began his career as a science and nanotechnology equity research analyst at Susquehanna International Group, authoring and marketing industry and equity research reports to hedge funds and portfolio managers. Dr. Anquetil holds a doctorate in bio-instrumentation from MIT, an MBA from Harvard Business School, and a master's degree from the ETH in Zurich and the University of Tokyo. His scientific work has appeared in peer-reviewed publications as well as mainstream media, including MIT Technology Review, Wired Magazine, PBS, and CNBC.